Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at...
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...